Does white blood cell count predict reduction in coronary heart disease mortality with pravastatin?
These data support the hypothesis that individuals with evidence of inflammation may obtain a greater benefit from statin therapy.
Lack of p27KiP1 protein expression in CRC is a negative prognostic marker and may therefore be useful in selecting early-stage patients more likely to benefit from adjuvant treatment.